ISPO opened abstract submissions and participation grants for its 2027 World Congress. Both matter more than conference-circuit coverage usually acknowledges.

The International Society for Prosthetics and Orthotics has issued a call for abstract submissions and participation grant applications for its 21st World Congress, scheduled for March 22–25, 2027. The announcement was reported by The O&P EDGE.

Neither of these is a routine item. The ISPO World Congress is the field’s principal international research gathering. The abstract call determines what evidence gets formally presented and debated across those four days. The participation grant program determines who can afford to show up. Both shape a feedback loop that influences clinical practice, device development priorities, and policy — sometimes on a years-long delay that obscures the connection.

What the abstract call is and what happens to submissions

An abstract submission is a short research summary — typically a structured paragraph or two — that describes a study, a clinical analysis, or a systematic review, submitted for consideration as a presentation or poster at the congress. ISPO reviews submissions and selects those that meet its criteria for scientific rigor, relevance, and novelty.

The submissions that get accepted are not just conference programming. They become part of the documented record of what O&P research was active in a given period. They drive citations. They inform clinical guidelines when bodies convening those guidelines look for what the evidence base actually says. Presentations at a major ISPO congress are how emerging findings — on socket technology, outcomes measurement, access disparities, rehabilitation protocols, device abandonment rates — reach a global audience of practitioners and researchers who can then replicate, challenge, or build on them.

The field’s knowledge base grows through this process. So does the set of questions that gets treated as worth asking. If particular topics are consistently underrepresented in abstract pools — because the researchers working on them can’t get to the congress, or because the funding base for those studies is thin — those gaps compound over time.

For practitioners and researchers with findings worth sharing: the abstract deadline and submission requirements will be in the official ISPO congress materials. The place to start is ispo.com or the congress’s dedicated site. Abstracts accepted for presentation typically require travel to present; the participation grant program is the relevant parallel track if that is a constraint.

What participation grants are and who historically needs them

International conferences cost money on multiple axes: registration fees, airfare, accommodation, visa fees and the time required to obtain them, and any income lost to travel days. For researchers at well-resourced institutions in countries without significant visa friction, these costs are often covered by grants, institutional travel budgets, or employer support. For researchers and practitioners elsewhere, they often are not.

ISPO’s participation grant program has historically been designed to address that gap — specifically to help attendees from low- and middle-income countries, early-career researchers, and practitioners without institutional travel funding participate in the congress. The program acknowledges that the barriers to attendance are structural rather than merit-based, and that the field loses something when they go unaddressed.

Eligibility criteria, grant amounts, and application deadlines for the 2027 congress are specified in the ISPO materials. Anyone considering applying should check those details directly through ispo.com rather than waiting for the information to filter through secondary sources; grant programs of this type typically close well before the conference registration window.

The structural problem the grants are trying to address

The relationship between where O&P expertise is concentrated and where O&P need is highest is inverted. Limb loss rates — from traumatic injury, from vascular disease, from diabetes, from conflict — are disproportionately high in lower-income countries and in lower-income populations within wealthier ones. The countries with the highest density of trained prosthetists, the most developed device markets, and the most active research infrastructure are not, as a rule, the same places.

That mismatch means the O&P research agenda — what gets studied, what outcomes get measured, what devices get developed, what clinical guidelines get written — is shaped substantially by the priorities of higher-resource settings. Research from lower-resource settings, on devices and techniques appropriate to those contexts, on access barriers specific to those populations, on the outcomes of different care pathways, is not absent; it is underrepresented relative to the burden those settings carry.

Participation grants are one mechanism for shifting that distribution at the margins. They are not a structural fix. But an ISPO World Congress where practitioners and researchers from a broader range of national and resource contexts present work generates a different set of findings than one where attendance self-selects for institutional wealth and geography.

This is not an abstract point. It affects which prosthetic designs get studied for durability in high-activity, variable-terrain settings. It affects what gets written into international clinical guidelines on amputation rehabilitation. It affects how device funders — including multilateral development organizations — understand what investment in O&P capacity in lower-income settings actually produces. The research presented at congresses like this one is part of the evidentiary basis those decisions draw on.

What to do with this now

If you are a researcher, practitioner, or educator with work relevant to prosthetics and orthotics — clinical findings, policy analysis, access research, device outcomes, educational program evaluation — the abstract submission process is the relevant track. Check deadlines early; they do not move.

If cost is a barrier to attendance and you would qualify for a participation grant, apply for it on the same timeline as your abstract, not after. The two processes are connected in practice even if they run through separate channels.

If you are a patient, family member, or advocate without a professional role in the field: the relevance here is indirect but real. The research that gets presented at the 2027 World Congress will filter — at different speeds, across different channels — into the evidence base that shapes what gets covered, what gets prescribed, and what gets built. Congresses like this are part of the infrastructure that produces the clinical guidelines your practitioners are working from.

Specific submission requirements, grant eligibility, and deadlines are available through ISPO directly. The O&P EDGE report is the source for this news item; for application details, go to the primary source.

---

Amputee News does not provide individualized medical, legal, insurance, or device-fitting advice. This article draws on the O&P EDGE report of the ISPO announcement and on general knowledge of how international O&P research congresses operate; for submission and grant specifics, consult ISPO’s official congress materials.